熒光定量PCR檢測(cè)惡性轉(zhuǎn)化人臍帶間充質(zhì)干細(xì)胞中DNA甲基化轉(zhuǎn)移酶的改變
[Abstract]:Background: according to the spontaneous malignant transformation of adult stem cells cultured in vitro and the theory of tumor stem cells, human umbilical cord mesenchymal stem cells may mutate in vitro, and there may be tumorigenic risk after in vivo transplantation. Therefore, the establishment of a sound safety detection procedure in vitro will play an active role in the clinical application of stem cells. Objective: to investigate the tumorigenic mechanism of human umbilical cord mesenchymal stem cells and the expression of DNA methyltransferase. Methods: human umbilical cord mesenchymal stem cells were isolated, cultured and expanded by tissue block adherent method. 3-methylcholanthracene was used to promote the malignant transformation of human umbilical cord mesenchymal stem cells, which were verified by morphological observation and nude mice tumorigenesis experiment. Pathological identification of tumorigenic tissues, primary cell culture and fluorescence quantitative PCR were used to detect the expression of DNA methyltransferase between human umbilical cord mesenchymal stem cells and tumor cells. Results and conclusion: (1) Human umbilical cord mesenchymal stem cells were treated with 3-methylcholanthracene to form malignant transformed cells with malignant growth and aninteger ploidy change in karyotype. Malignant masses could be formed after injection into nude mice. (2) the expression of DNA methyltransferase gene in malignant transformed tumor cells (experimental group) was significantly higher than that in human umbilical cord mesenchymal stem cells cultured with dimethyl sulfoxide (control group) by fluorescence quantitative PCR. (3) the results showed that human umbilical cord mesenchymal stem cells could undergo malignant transformation under certain conditions, including morphological changes and epigenetic changes. DNA methyltransferase can be used as a further research direction to prevent tumor formation after stem cell transplantation.
【作者單位】: 汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院兒科;汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院轉(zhuǎn)化醫(yī)學(xué)中心;
【基金】:廣東省醫(yī)學(xué)科學(xué)技術(shù)研究基金(B2013276)~~
【分類號(hào)】:R457.7
【參考文獻(xiàn)】
相關(guān)期刊論文 前3條
1 唐秋靈;陳秋蓉;陳輝;陳業(yè)增;賴秀蘭;劉思征;謝慶東;賀谷雨;馬廉;;3-甲基膽蒽誘導(dǎo)人臍帶間充質(zhì)干細(xì)胞的惡性轉(zhuǎn)化[J];中華實(shí)用兒科臨床雜志;2013年21期
2 田臻;張志愿;李蕾;李江;;涎腺腺樣囊性癌DNA甲基轉(zhuǎn)移酶與抑癌基因甲基化[J];中華口腔醫(yī)學(xué)雜志;2006年07期
3 ;Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells[J];Chinese Medical Journal;2005年23期
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳業(yè)增;唐秋靈;陳秋蓉;賴秀藍(lán);邱曉燕;鄭澤鑫;李偉中;;熒光定量PCR檢測(cè)惡性轉(zhuǎn)化人臍帶間充質(zhì)干細(xì)胞中DNA甲基化轉(zhuǎn)移酶的改變[J];中國(guó)組織工程研究;2017年21期
2 袁麗麗;張炳強(qiáng);王瑋瑋;李蒙;張嘉澍;胡鑫童;;人臍帶間充質(zhì)干細(xì)胞體外誘導(dǎo)分化胰島樣細(xì)胞及形態(tài)學(xué)觀察[J];濟(jì)寧醫(yī)學(xué)院學(xué)報(bào);2017年02期
3 趙曉彬;楊子微;高振宇;;miR-363、Eomes在人臍帶間充質(zhì)干細(xì)胞誘導(dǎo)神經(jīng)樣細(xì)胞中的表達(dá)及意義[J];山東醫(yī)藥;2017年02期
4 賴秀藍(lán);馬廉;;間充質(zhì)干細(xì)胞的臨床應(yīng)用及產(chǎn)業(yè)化前景[J];中國(guó)小兒血液與腫瘤雜志;2016年06期
5 宋新苗;顏次慧;呂夢(mèng)果;于文文;張新偉;任秀寶;;MCP-1/CCR2軸促進(jìn)臍帶間充質(zhì)干細(xì)胞向肺癌組織歸巢[J];中國(guó)腫瘤生物治療雜志;2016年01期
6 郝春光;王凌峰;段霞光;黃再青;李俊亮;;微孔化羊脫細(xì)胞真皮基質(zhì)復(fù)合人臍帶間充質(zhì)干細(xì)胞的實(shí)驗(yàn)研究[J];中華損傷與修復(fù)雜志(電子版);2016年01期
7 崔o,
本文編號(hào):2490865
本文鏈接:http://sikaile.net/linchuangyixuelunwen/2490865.html